Shilpa Medicare Limited (SHILPAMED) — Announcement | 7 July 2026

StockFin.ai

Try Free

India Ratings upgraded Shilpa Medicare's bank loan facilities to IND AA- with a Positive outlook, while Shilpa Pharma's facilities were also upgraded to IND AA- and IND A1+ respectively, reflecting improved creditworthiness and stable outlooks for both entities.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SHILPAMED ✨ Ask AI About This

About Shilpa Medicare Limited (SHILPAMED)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹9,356.63 Cr P/E: 106.1

View full SHILPAMED stock details →

📡 Get AI alerts when SHILPAMED files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SHILPAMED — Free

💡 Ask AI about this filing

"How does this announcement affect Shilpa Medicare Limited's outlook?" "What did Shilpa Medicare Limited announce on 7 July 2026?" "Is this positive or negative for SHILPAMED?"

Ask AI Free →

📊 More SHILPAMED filings

See all SHILPAMED filings →

🔥 Also filed on 7 July 2026

SHRIRAMFIN Shriram Finance Limited Corporate Action TATACAP Tata Capital Limited Corporate Action RSYSTEMS R Systems International Limited Announcement SAMBHV Sambhv Steel Tubes Limited Announcement SRGHFL SRG Housing Finance Limited Financial Results TI Tilaknagar Industries Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when SHILPAMED files new disclosures

Track SHILPAMED filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SHILPAMED — Free

Free account · 2 AI queries/day